A Phase II study of paclitaxel and ifosfamide for patients with advanced refractory carcinoma of the urothelium. [electronic resource]
Producer: 19990806Description: 514-8 p. digitalISSN:- 0008-543X
- Adult
- Aged
- Antineoplastic Combined Chemotherapy Protocols -- adverse effects
- Carcinoma, Transitional Cell -- drug therapy
- Drug Administration Schedule
- Drug Evaluation
- Female
- Humans
- Ifosfamide -- administration & dosage
- Male
- Middle Aged
- Paclitaxel -- administration & dosage
- Survival Analysis
- Urologic Neoplasms -- drug therapy
- Urothelium
No physical items for this record
Publication Type: Clinical Trial; Clinical Trial, Phase II; Journal Article; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.